… have radically modified our knowledge of neuroendocrine tumor (NET) biology, pathogenesis
and management [1]. NETs derive from neuroendocrine cells of the diffuse endocrine …

… Another therapeutic option for patients is the use of radionuclides to target NETs, although
no randomised phase III trials have reported data. Patients whose tumours continue to grow …

… Treatment is therefore a challenge for clinicians, although the landscape of the therapeutic
options has considerably expanded in the last decades. Surgery remains the cornerstone of …

… patients with neuroendocrine tumors assigned to 22 different therapies. A … therapies for
pancreatic neuroendocrine tumors and 5 therapies for gastrointestinal neuroendocrine tumors …

… and may serve as an important therapeutic option. … of neuroendocrine tumors have led to
significant changes in our understanding and treatment options for patients with these tumors. …

… therapeutic options in NEN has considerably expanded in the last years, thanks to the growing
knowledge of tumor … The current systemic therapies for locally advanced or metastatic G1/…

Treatment options for neuroendocrine tumors (NETs) and … -emitting peptide receptor
radionuclide therapy (PRRT), and … data on emerging treatments for neuroendocrine neoplasms. …

… Well- to moderately differentiated neuroendocrine tumors (NET) are a heterogeneous group
of malignancies for which a range of therapeutic options have been employed. For patients …

… of the currently available treatment options for advanced functional as well as non-… therapeutic
options and clinical trials. We will not discuss systemic chemotherapy or neuroendocrine …

… Well-differentiated neuroendocrine tumors (NETs) represent a group of malignancies with
… resistant to SSAs, or rapidly progressing, multiple therapeutic options exist, depending on …